Bi E - Search Results

1

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.

Wang Q, Zhao D, Xian M, Wang Z, Bi E, Su P, Qian J, Ma X, Yang M, Liu L, Zu Y, Pingali SR, Chen K, Cai Z, Yi Q. Wang Q, et al. Among authors: bi e. Blood. 2020 Nov 26;136(22):2557-2573. doi: 10.1182/blood.2020005795. Blood. 2020. PMID: 32582913 Free PMC article.

2

Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro.

Li H, Lu Y, Qian J, Zheng Y, Zhang M, Bi E, He J, Liu Z, Xu J, Gao JY, Yi Q. Li H, et al. Among authors: bi e. J Bone Miner Res. 2014 Dec;29(12):2666-75. doi: 10.1002/jbmr.2294. J Bone Miner Res. 2014. PMID: 24916315 Free PMC article.

3

Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.

Li Y, Zheng Y, Li T, Wang Q, Qian J, Lu Y, Zhang M, Bi E, Yang M, Reu F, Yi Q, Cai Z. Li Y, et al. Among authors: bi e. Oncotarget. 2015 Sep 15;6(27):24218-29. doi: 10.18632/oncotarget.4523. Oncotarget. 2015. PMID: 26155942 Free PMC article.

4

CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma.

Zhang L, Bi E, Hong S, Qian J, Zheng C, Wang M, Yi Q. Zhang L, et al. Among authors: bi e. Oncotarget. 2015 Nov 3;6(34):36032-40. doi: 10.18632/oncotarget.5506. Oncotarget. 2015. PMID: 26447613 Free PMC article.

5

Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.

Zheng Y, Wang Q, Li T, Qian J, Lu Y, Li Y, Bi E, Reu F, Qin Y, Drazba J, Hsi E, Yang J, Cai Z, Yi Q. Zheng Y, et al. Among authors: bi e. J Natl Cancer Inst. 2016 Jul 5;108(11):djw131. doi: 10.1093/jnci/djw131. Print 2016 Nov. J Natl Cancer Inst. 2016. PMID: 27381622 Free PMC article.

6

Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.

Wang Q, Lu Y, Li R, Jiang Y, Zheng Y, Qian J, Bi E, Zheng C, Hou J, Wang S, Yi Q. Wang Q, et al. Among authors: bi e. Leukemia. 2018 Jan;32(1):176-183. doi: 10.1038/leu.2017.193. Epub 2017 Jun 19. Leukemia. 2018. PMID: 28626216 Free PMC article.

7

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T_H9 cells programmed by IL-7.

Bi E, Ma X, Lu Y, Yang M, Wang Q, Xue G, Qian J, Wang S, Yi Q. Bi E, et al. Sci Signal. 2017 Oct 10;10(500):eaak9741. doi: 10.1126/scisignal.aak9741. Sci Signal. 2017. PMID: 29018172 Free PMC article.

8

Cholesterol negatively regulates IL-9-producing CD8⁺ T cell differentiation and antitumor activity.

Ma X, Bi E, Huang C, Lu Y, Xue G, Guo X, Wang A, Yang M, Qian J, Dong C, Yi Q. Ma X, et al. Among authors: bi e. J Exp Med. 2018 Jun 4;215(6):1555-1569. doi: 10.1084/jem.20171576. Epub 2018 May 9. J Exp Med. 2018. PMID: 29743292 Free PMC article.

9

Th9 Cells Represent a Unique Subset of CD4⁺ T Cells Endowed with the Ability to Eradicate Advanced Tumors.

Lu Y, Wang Q, Xue G, Bi E, Ma X, Wang A, Qian J, Dong C, Yi Q. Lu Y, et al. Among authors: bi e. Cancer Cell. 2018 Jun 11;33(6):1048-1060.e7. doi: 10.1016/j.ccell.2018.05.004. Cancer Cell. 2018. PMID: 29894691 Free PMC article.

10

E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.

Bi E, Li R, Bover LC, Li H, Su P, Ma X, Huang C, Wang Q, Liu L, Yang M, Lin Z, Qian J, Fu W, Liu YJ, Yi Q. Bi E, et al. J Clin Invest. 2018 Nov 1;128(11):4821-4831. doi: 10.1172/JCI121421. Epub 2018 Oct 2. J Clin Invest. 2018. PMID: 30277474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters